Pfizer Inc. Pulls Leukemia Drug Mylotarg From U.S. Market After Deaths, No Proven Benefit
(Reuters) - Drugmaker Pfizer Inc is pulling a decade-old leukemia medicine off the U.S. market after a study found a higher death rate and no benefit for patients.